New vaccines are presently under development and in testing for the control of infectious
diseases, including human immunodeficiency virus (HIV) and tuberculosis. Several of these …

Respiratory syncytial virus (RSV) is the most important cause of viral lower respiratory tract
illness (LRI) in infants and children worldwide and causes significant LRI in the elderly and …

Respiratory syncytial virus (RSV) is a leading cause of hospitalization in infants. A formalin-
inactivated RSV vaccine was used to immunize children and elicited nonprotective …

The present invention relates generally to adjuvants, and in particular to methods and
products utilizing a synergistic combination of immunostimulatory oligonucleotides having at …

Formalin-inactivated respiratory syncytial virus (RSV) vaccine preparations have been
shown to cause enhanced disease in naive hosts following natural infection. In this study we …

ABSTRACT CD1d-deficient mice have normal numbers of T lymphocytes and natural killer
cells but lack Vα14+ natural killer T cells. Respiratory syncytial virus (RSV) …

Eosinophil Response Against Classical and Emerging Respiratory Viruses: COVID-19 Short
running title: Eosinophils and respirator Page 1 1 J Investig Allergol Clin Immunol 2021; Vol …

Asthma is a common and debilitating disease that has substantially increased in prevalence
in Western Societies in the last 2 decades. Respiratory tract infections by respiratory …

The induction of protective immunity stemming from vaccines delivered by mucosal routes is
dependent on the development of safe and effective mucosal adjuvants. The …

Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract disease
in infants and the elderly, but no safe and effective RSV vaccine is yet available. For reasons …